Sunshine Biopharma, Inc. (SBFM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.06
-1.85%
Mkt Cap $2.52M
No analyst coverage available
We don't have analyst ratings or price target data for Sunshine Biopharma, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.